Molecular mimicry in the recognition of glycosphingolipids by Galα3Galβ4GlcNAcβ-binding Clostridium difficile toxin A, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor
Authors:
- Maria Ölwegård HalvarssonMHMaria Ölwegård Halvarsson
- Jonas ÅngströmJÅJonas Ångström
- Karl-Anders KarlssonKKKarl-Anders Karlsson
Open Access
- 1 September 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 6 (6) , 599-609
Abstract
Glycoconjugates with terminal Galα3Galβ4GlcNAcβ sequences have been shown to be recognized by three carbohydrate-binding proteins: toxin A of Clostridium difficile, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13. However, the biological significance of this binding specificity in humans is unclear, since unsubstituted Galα3Galβ4GlcNAcβ sequences are not found in human tissues, due to suppression of the gene coding for the enzyme Galα3-transferase. To explore this inconsistency, the binding of toxin A, human natural anti α-galactosyl IgG, and the Gal-13 monoclonal antibody to various glycosphingolipids was examined using the thin-layer chromatogram binding assay. The binding to Galα3Galβ4GlcNAcβ-terminated glycosphingolipids of rabbit erythrocytes was confirmed. A minor binding-active compound was also detected in the non-acid glycosphingolipid fraction of human erythrocytes. This glycosphingolipid was isolated and characterized by EI mass spectrometry, gas chromatography-EI mass spectrometry after degradation, and proton NMR spectroscopy, as GalNAcβ3Galβ4GlcNAcβ3Galβ4Glcβ1Cer, corresponding to the x2 glycosphingolipid isolated before from this source. Two additional binding-active glycosphingolipids were found. One was GalNAcα3Galβ4GlcNAcβ4Glcβ1Cer produced from blood group A-active GalNAcα3(Fucβ2)Galβ4GlcNAcβ3Galβ4Glcβ1Cer by acid-induced defucosylation. The other was GlcNAcα3Galβ4GlcNAcβ4Glcβ1Cer, generated from NeuGcαGalβ4GlcNAcβ3Galfβ4GlcNAcβ1Cer by enzymatic hydrolysis. A number of other glycosphingolipid sequences, including the human Lex, Ley and I blood group determinants suggested to act as receptors for toxin A, were not recognized by the three ligands. Despite the different terminal substituents and anomerity of the binding-active glycosphingolipids, calculated minimum energy conformations demonstrated topographical similarities in the spatial orientation of the terminal trisaccharides, possibly accounting for the crossreactivity.Keywords
This publication has 12 references indexed in Scilit:
- Structural characterization of x2 glycosphingolipid, its extended form, and its sialosyl derivatives: accumulation associated with the rare blood group p phenotypeBiochemistry, 1992
- Glycosphingolipids of Human Large Intestine: Detailed Structural Characterization with Special Reference to Blood Group Compounds and Bacterial Receptor Structures1The Journal of Biochemistry, 1991
- Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and YInfection and Immunity, 1991
- DREIDING: a generic force field for molecular simulationsThe Journal of Physical Chemistry, 1990
- [34] Mass spectrometry of mixtures of intact glycosphingolipids1990
- Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13.Journal of Biological Chemistry, 1987
- Application of a simple methylation procedure for the analyses of glycosphingolipidsCarbohydrate Research, 1987
- A new glycolipid antigen isolated from human erythrocyte membranes reacting with antibodies directed to globo-N-tetraosylceramide (globoside).Journal of Biological Chemistry, 1982
- Detection of gangliosides that bind cholera toxin: Direct binding of 125I-labeled toxin to thin-layer chromatogramsAnalytical Biochemistry, 1980
- A Ceramide Pentasaccharide of Human Erythrocyte MembraneJournal of Biological Chemistry, 1974